CMBA
IBB icon

C.M. Bidwell & Associates’s iShares Biotechnology ETF IBB Stock Holding History

C.M. Bidwell & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-450
Closed -$48K – 407
2017
Q4 		$48K Hold
450
– – 0.04% 246
2017
Q3 		$50K Hold
450
– – 0.08% 175
2017
Q2 		$47K Buy
+450
New +$44.3K 0.01% 202

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

C.M. Bidwell & Associates's IBB Position: Q1 2018 in Review

C.M. Bidwell & Associates sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 450 shares — an estimated $48K sold.

C.M. Bidwell & Associates first reported a position in IBB in Q2 2017 and held it in 3 quarters. The position peaked at $50K in Q3 2017. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

  • C.M. Bidwell & Associates reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 450 iShares Biotechnology ETF shares in Q1 2018, an estimated $48K.
  • C.M. Bidwell & Associates first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 3 quarters.
  • C.M. Bidwell & Associates's iShares Biotechnology ETF position peaked at $50K in Q3 2017.
  • 608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2018, filed 11 May 2018.